Dose estimation for atomic bomb survivor studies: its evolution and present status
- PMID: 16808610
- DOI: 10.1667/RR3546.1
Dose estimation for atomic bomb survivor studies: its evolution and present status
Abstract
In the decade after the bombings of Hiroshima and Nagasaki, several large cohorts of survivors were organized for studies of radiation health effects. The U.S. Atomic Bomb Casualty Commission (ABCC) and its U.S./Japan successor, the Radiation Effects Research Foundation (RERF), have performed continuous studies since then, with extensive efforts to collect data on survivor locations and shielding and to create systems to estimate individual doses from the bombs' neutrons and gamma rays. Several successive systems have been developed by extramural working groups and collaboratively implemented by ABCC and RERF investigators. We describe the cohorts and the history and evolution of dose estimation from early efforts through the newest system, DS02, emphasizing the technical development and use of DS02. We describe procedures and data developed at RERF to implement successive systems, including revised rosters of survivors, development of methods to calculate doses for some classes of persons not fitting criteria of the basic systems, and methods to correct for bias arising from errors in calculated doses. We summarize calculated doses and illustrate their change and elaboration through the various systems for a hypothetical example case in each city. We conclude with a description of current efforts and plans for further improvements.
Similar articles
-
Current risk estimates based on the A-bomb survivors data - a discussion in terms of the ICRP recommendations on the neutron weighting factor.Radiat Prot Dosimetry. 2007;126(1-4):423-31. doi: 10.1093/rpd/ncm087. Epub 2007 May 28. Radiat Prot Dosimetry. 2007. PMID: 17533156
-
Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.Radiat Prot Dosimetry. 2008;132(2):156-65. doi: 10.1093/rpd/ncn264. Epub 2008 Oct 20. Radiat Prot Dosimetry. 2008. PMID: 18936088
-
Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.Health Phys. 2006 Jun;90(6):554-64. doi: 10.1097/01.HP.0000184917.94232.cd. Health Phys. 2006. PMID: 16691103
-
Cancer and non-cancer effects in Japanese atomic bomb survivors.J Radiol Prot. 2009 Jun;29(2A):A43-59. doi: 10.1088/0952-4746/29/2A/S04. Epub 2009 May 19. J Radiol Prot. 2009. PMID: 19454804 Review.
-
Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.Health Phys. 2015 Dec;109(6):582-600. doi: 10.1097/HP.0000000000000395. Health Phys. 2015. PMID: 26509626 Review.
Cited by
-
Potential impacts of radon, terrestrial gamma and cosmic rays on childhood leukemia in France: a quantitative risk assessment.Radiat Environ Biophys. 2013 May;52(2):195-209. doi: 10.1007/s00411-013-0464-y. Epub 2013 Mar 26. Radiat Environ Biophys. 2013. PMID: 23529777
-
Role of Ionizing Radiation in Neurodegenerative Diseases.Front Aging Neurosci. 2018 May 14;10:134. doi: 10.3389/fnagi.2018.00134. eCollection 2018. Front Aging Neurosci. 2018. PMID: 29867445 Free PMC article. Review.
-
Autoradiographic analysis of internal plutonium radiation exposure in Nagasaki atomic bomb victims.Heliyon. 2018 Jun 29;4(6):e00666. doi: 10.1016/j.heliyon.2018.e00666. eCollection 2018 Jun. Heliyon. 2018. PMID: 30003160 Free PMC article.
-
Selection of reference groups in the Life Span Study of atomic bomb survivors.Eur J Epidemiol. 2017 Dec;32(12):1055-1063. doi: 10.1007/s10654-017-0337-9. Epub 2017 Dec 4. Eur J Epidemiol. 2017. PMID: 29204903
-
Radiation and smoking effects on lung cancer incidence among atomic bomb survivors.Radiat Res. 2010 Jul;174(1):72-82. doi: 10.1667/RR2083.1. Radiat Res. 2010. PMID: 20681801 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources